Vitamin D3 seems more appropriate than D2 to sustain adequate levels of 25OHD: A pharmacokinetic approach

European Journal of Clinical Nutrition

Volumn 69, Issue 6, 2015, Pages 697-702

  Oliveri, B ^a   Mastaglia, S R ^a   Brito, G M ^a   Seijo, M ^a   Keller, G A ^b   Somoza, J ^a   Diez, R A ^b   Di Girolamo, G ^b  

^a Hospital de Clínicas José de San Martín   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; COLECALCIFEROL; ERGOCALCIFEROL; PLACEBO; 25 HYDROXYERGOCALCIFEROL; CALCIFEDIOL; CALCIUM;

ABSENCE OF SIDE EFFECTS; ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CONTROLLED STUDY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SAFETY; FEMALE; HUMAN; HUMAN EXPERIMENT; LOADING DRUG DOSE; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; ADVERSE EFFECTS; ARGENTINA; BIOLOGICAL MODEL; BLOOD; COMPARATIVE STUDY; DIET SUPPLEMENTATION; FOLLOW UP; HALF LIFE TIME; HOSPITAL; HOSPITAL PERSONNEL; KINETICS; METABOLISM; MIDDLE AGED; UNIVERSITY HOSPITAL; URINE; VITAMIN D DEFICIENCY; YOUNG ADULT;

25-HYDROXYVITAMIN D 2; ADULT; ARGENTINA; CALCIFEDIOL; CALCIUM; CHOLECALCIFEROL; DIETARY SUPPLEMENTS; ERGOCALCIFEROLS; FEMALE; FOLLOW-UP STUDIES; HALF-LIFE; HOSPITALS, UNIVERSITY; HOSPITALS, URBAN; HUMANS; KINETICS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PERSONNEL, HOSPITAL; SINGLE-BLIND METHOD; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84930472596     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2015.16     Document Type: Article

References (42)

1. Lips P. Worldwide status of vitamin D nutrition. J Steroid Biochem Mol Biol 2010; 121: 297-300
2. Mithal A, Wahl DA, Bonjour JP, Burckardt P, Dawson-Hughes B, Eisman JA, et al. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 2009; 20: 1807-1820
3. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006; 84: 18-28
4. Bikle D. Nonclassic actions of vitamin D. J Clin Endocrinol Metab 2009; 94: 26-34
5. Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (Cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomized double blind controlled trial. Br Med J 2003; 326: 469
6. Mastaglia SR, Mautalen CA, Parisi MP, Oliveri B. 10.000 UI of oral vitamin D2 per day are required to rapidly reach adequate 25OHD levels in osteoporotic women. Eur J Clin Nutr 2006; 60: 1-7
7. Pepper KJ, Judd SE, Nanes M, Tangpricha V. Evaluation of vitamin D repletion regimens to correct vitamin D status in adults. Endocr Pract 2009; 15: 95-103
8. Bischoff-Ferrari HA, Shao A, Dawson-Hughes B, Hathcock J, Giovannucci E, Willet WC. Benefit-risk assessment of vitamin D supplementation. Osteoporos Int 2010; 7: 1121-1132
9. Bikle D, Adams J, Christakos S. Vitamin D: production, metabolism, mechanism of action, and clinical requirements. In: Clifford Rosen (ed). Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 7th edn. American Society for Bone and Mineral Research: Washington, DC, USA, pp 141-149, 2008
10. Tjellesen L, Hummer L, Christiansen C, Rodbro P. Serum concentrations of vitamin D metabolites during treatment with vitamin D2 and D3 in normal premenopausal women. Bone Miner 1986; 1: 407-413
11. Trang HM, Cole DE, Rubin LA, Pierratos A, Siu S, Vieth R. Evidence that vitamin D3 increases 25-hydroxyvitamin D more efficiently than vitamin D2. Am J Clin Nutr 1998; 68: 854-858
12. Armas LA, Hollis BW, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 2004; 89: 5387-5391
13. Rapuri PB, Gallagher JC, Haynatzki G. Effect of vitamin D2 and D3 supplement use on serum 25(OH)D concentration in elderly women in summer and winter. Calcif Tissue Int 2004; 74: 150-156
14. Romagnoli E, Mascia ML, Cipriani C, Fassino V, Mazzei F, D'Erasmo E, et al. Short and long term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. J Clin Endocrinol Metab 2008; 93: 3015-3020
15. Holick MF, Biancuzzo RM, Chen TC, Klein EK, Young A, Bibuld D, et al. Vitamin D2 is as effective as vitamin D3 in mantaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 2008; 93: 677-681
16. Leventis P, Kiely PD. The tolerability and biochemical effects of high dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency. Scand J Rheumatol 2009; 38: 149-153
17. Glendenning P, Chew GT, Seymour HM, Guillet MJ, Goldsain PR, Inderjeeth CA, et al. Serum 25 hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol. Bone 2009; 45: 870-875
18. Biancuzzo RM, Young A, Bibuld D, Cai MH, Winter MR, Klein EK, et al. Fortification of orange juice with vitamin D2 or vitamin D3 is as effective as an oral supplement in maintaining vitamin D status in adults. Am J Clin Nutr 2010; 91: 1621-1626
19. Heaney RP, Recker RR, Grote J, Horst RL, Armas LAG. Vitamin D3 is more potent than vitamin D2 in humans. J Clin Endocrinol Metab 2011; 96: E447-E442
20. Binkley N, Gemar D, Engelke J, Gangnon R, Ramamurthy R, Krueger D, et al. Evaluation of ergocalciferol or cholecalciferol dosing, 1600UI daily or 50000IU monthly in older adults. J Clin Endocrinol Metab 2011; 96: 981-988
21. Seijo M, Mastaglia SR, Brito G, Somoza J, Oliveri B. Es equivalente la suplementación diaria con vitamina D2 o vitamina D3 en adultos mayores? Medicina 2012; 72: 195-200
22. Vieth R, Chan PCR, Mac Fairline GD. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect levels. Am J Clin Nutr 2001; 73: 288-294
23. Brito GM, Mastaglia SR, Goedelman C, Seijo M, Somoza J, Oliveri B. Estudio exploratorio de la ingesta y prevalencia de vitamina D en mujeres mayores de 65 años que viven en hogar familiar o en residencias para autoválidos de la Ciudad de Buenos Aires. Nutrición Hospitalaria 2013; 28: 816-822
24. IOM. Dietary Reference Intake for calcium and vitamin D. The National Academies Press: Washington DC, 2011
25. Bouillon R, Van Schoor NM, Gielen E, Boonen S, Mathieu C, Vanderschueren D, et al. Optimal vitamin D status: a critical analysis on the basis of evidence-based medicine. J Clin Endocrinol Metab 2013; 98: E1283-E1304
26. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 1911-1930
27. Hsuan FC. Estimating treatment means in a mixed-effect ANOVA model for bioequivalence studies. Biometrics1993 49: 703-713
28. Chow SC, Liu JP. Design and analysis of bioavailability and bioequivalence studies, 2nd edn. Marcel Dekker: New York, NY, USA, 2000
29. Anderson S, Hauck WW A new procedure for testing equivalence in comparative bioavailability and other clinical trials. Comm Statist Theory Methods 1983; 12: 2663-2692
30. Schuirmann DJ A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmacokinet Biopharm 1987; 15: 657-680
31. US Food and Drug Administration Guidance for Industry. Statistical approaches to establishing bioequivalence. http://www.fda.gov/downloads/Drugs/Guidance ComplianceRegulatoryInformation/Guidances/ucm070244.pdf. Last accessed on 15 October 2013
32. Wacker M, Holick FH. Vitamin D. Effects on skeletal and extraskeletal health and the need for supplementation. Nutrients 2013; 5: 111-148
33. Tripkovic L, Lambert H, Hart K, Smith CP, Bucca G, Penson S, et al. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-Analysis. Am J Clin Nutr 2012; 95: 1357-1364
34. Ladizesky M, Oliveri B, Mautalen CA. Niveles séricos de 25-hidroxivitamina D en la población normal de Buenos Aires, su variación estacional. Medicina 1987; 47: 268-272
35. Ladizesky M, Lu Z, Oliveri MB, San Román N, Holick M, Mautalen CA. Solar ultraviolet-B radiation and photoproduction of vitamin D in Central and Southern areas of Argentina. J Bone Min Res 1995; 10: 545-549
36. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003; 77: 204-210
37. Hollis BW. Comparison of equilibrium and disequilibrium assay conditions for ergocalciferol, cholecalciferol and their major metabolites. J Steroid Biochem 1984; 12: 81-86
38. Nimitphong H, Saetung S, Chanprasertyotin S, Chailurkit LO, Ongphiphadhanakul B. Changes in circulating 25-hydroxyvitamin D according to vitamin D binding protein genotypes after vitamin D3 or D2 supplementation. Nutr J 2013; 12: 39
39. Nilsson SF, Ostberg L, Peterson PA. Binding of vitamin D to its human carrier plasma protein 1972. Biochem Byophys Res Commun 1972; 46: 1380-1387b
40. Schuster I. Cytochromes P450 are essential players in the vitamin D signaling system. Biochim Biophys Acta 2011; 1814: 186-199
41. Spedding S, Vanlint S, Morris H, Seragg R. Does vitamin D sufficiency equate to a single serum 25-hydroxyvitamin D level or are different levels required for non-skeletal diseases? Nutrients 2013; 5: 5127-5139
42. Hollis BW, Wagner C. The role of the parent compound vitamin D with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes. J Clin Endocr Metab 2013; 98: 4619-4628